ABSTRACT
INTRODUCTION
Oral route is very admired and commodious route of a drug administration. Oral route of administration has been used for both conventional and novel drug delivery system. In the modern era, sustained release dosage form is suppressing the use of conventional dosage form. 1 The sustained release tablet provides uniform release of drug over a long period of time. Controlled release dosage form covers a wide range of prolonged action formulation which provides continuous release of their active ingredient at a predetermined rate and time. 2 Sustained or controlled drug delivery system is to reduce the frequency of dosing or to increase the effectiveness of drug by localization at the site of action, reducing dose required, providing continuous drug delivery, reduce incidence of adverse effect and maintain drug concentration in system. 1, 3 Matrix tablets serve as an important tool for oral extended-release dosage forms. Hence, various problems like patient compliance, drug targeting, local side effects, frequent administration and fluctuations in blood concentration levels, associated with their counterparts, therefore the conventional dosage forms restricted. A matrix tablet is the oral solid dosage form in which the drug or active ingredient is homogeneously dispersed throughout the hydrophilic or hydrophobic matrices which serve as release rate retardants. 1, 4 Polymers are high molecular weight compound originate from natural and synthetic source. Hydrophilic polymer (HPMC K4M) basically the cellulose derivative use of matrices, which satisfy the key criteria of release pattern by swelling property. HPMC is a partly o-methylated and o-(2-hydroxypropylated) cellulose with a molecular weight 10,000-1, 5000,000. Hydrophobic polymer (acacia gum) reduced the rate and extent of drug release due to reduced porosity of matrix. Acacia is a complex loose aggregate of sugars and hemiacetal. It is an acidic polysaccharide containing D-galactose, L-arabinose, L-rhamanose, D-glucuronic acid with a molecular weight of approximately 240,000-500,000. 5, 6 Both HPMC K4M and acacia gums are cellulose polymer based matrix which forms hydrogel due to simultaneous migration to the matrix. 3 Diclofenac sodium is 2-[2,6dichlorophenyl-amino] phenyl acetate and soluble in water. It is a Non-Steroidal Anti-Inflammatory Drug (NSAIDs) with analgesic activity. It inhibits PG synthesis and is somewhat COX-2 selective. It is well absorbed orally, 99% protein bound, metabolized and excreted both in urine and bile. 6 
MATERIALS AND METHOD

Materials
Diclofenac sodium was received as a gift sample from Alchem Laboratories, Baddi, India. All other ingredients such as HPMC K4M, Acacia, lactose, magnesium stearate and talc were purchased from Central Drug House (CDH) New Delhi, India. All ingredients used were of analytical grade.
Method
Sustained release tablets of diclofenac sodium using varying concentration of natural (Acacia) and synthetic (HPMC K4M) polymers were prepared by direct compression method. Other ingredients like lactose was used as diluent, magnesium stearate as lubricant and talc as glidant. All the excipients along with API weighed as shown in Table 1 and passed through sieve no.20. Then, all ingredients were mixed following geometric mixing excluding glidant and lubricant for 15 minutes. 7 The powder blend was thoroughly mixed with talc and magnesium stearate and compressed into a 400 mg tablet using a single rotatory punching machine (KI-150, Khera Instruments Ltd. New Delhi, India).
EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS
Pre-compressional studies of powder blend
A preformulation study is the first step in sane drug development. All studies which are performed prior to the development of dosage form to reduce error and provide a remunerative data to carry out dosage form development for the treatment of various diseases.
Angle of repose
It is defined as the angle of heap to the horizontal plane. Angle of repose was determined by using fixed funnel method. Specified amount of powder drug was transferred to the funnel keeping the orifice of the funnel blocked by thumb. 8 When powder was cleared from funnel then measured its angle of repose.
Angle of repose (θ) = tan -1 h/r
Bulk density
It is the ratio of bulk mass of powder to the bulk volume. It is calculated by this formula-
Bulk density = weight of powder bulk/Bulk volume
Tapped density
It is the ratio of the weight of blend to the minimum volume occupied in measuring cylinder by powder. Measuring cylinder containing the porous mass of powder was tapped using tapped density apparatus. 8 
Tapped density = weight of powder blend/Tapped volume of packing
Compressibility Indices
Carr's index
Based on the apparent bulk density and the tapped density, the percentage compressibility of the powder mixture was determined by the following formula.
8,9 Carr's index = Tapped density-Bulk density × 100 Tapped Density
Hausner's ratio
It is an indirect index of ease of measuring of powder flow. Lower Hausner's ratio (<1.25) indicates better flow properties than higher ones (>1.25).
Hausner's ratio = Tapped density Bulk density
POST-COMPRESSIONAL STUDIES OF PREPARED MATRIX TABLETS
The matrix tablets were evaluated for appearance, thickness, weight variation, hardness and friability. All the evaluation parameters of all formulations are given in (Table 2) .
Physical Appearance
The general appearance and urbanity of tablet were studied visually. The tablet was round in shape, unstained in color, smooth texture, and odorless.
Thickness
The tablet thickness was calculated by Vernier calipers. Tablet was put in between two jaws vertically and measured thickness. It is expressed in mm.
8,9
Weight variation
The weight of 20 tablets was measured and average weight was calculated. The individual weight of each tablet was measured to determine its variation. Weight variation was determined by comparison of individual tablet weight with average weight.
8,9
Hardness
The tablet hardness was determined by Monsanto hardness tester. The tablet was fitted lengthwise between plunger and force applied. Noted down the pressure at which tablet was crushed. It is measured in Kg/cm 2 . 6 tablets were used for this study. 
Friability
It is calculated by Roche friability apparatus. Preweighed six tablets were subjected to the device which provided combined effect of shock and abrasion from height of six inches with each rotation, at 25 rpm speed and operated for 100 revolutions. Tablets were dusted and re-weighed. 9, 10 Compressed tablets that lose less than 0.5-1.0% of their weight were generally considered acceptable. It is expressed in percentage (%) and calculated by the following formula:
Friability (%) = Initial weight-Final weight × 100
Initial weight
Drug Content Uniformity
The prepared formulation of Diclofenac sodium was weight and crushed. Powder equivalent to 50 mg of diclofenc sodium was weighed and shaken with 10 ml of methanol in 100 ml volumetric flask and filtered. The aliquot (1 ml) was taken and make up its volume up to 100 ml with methanol and absorbance was taken at 285 nm using UV spectrophotometer (UV-1601, Shimadzu, Japan). Drug content was determined by using standard curve of diclofenac sodium
In vitro drug release study
In vitro drug release studies were carried out using USP type II (paddle type) apparatus (Lab India Dissolution apparatus D5 8000). Dissolution medium was 900 ml phosphate buffer saline (pH 6.8) with paddle rotation at 75 rpm and temperature was maintained at 37 ± 1°C. Aliquots of 5 ml were withdrawn after each hour and equivalent amount of fresh buffer maintained at same temperature was replaced to maintain sink conditions. 6 The samples were analyzed for diclofenac sodium content at 276 nm by UV-spectrophotometer and calculated the drug release using calibration curve of diclofenac sodium.
In vitro drug release kinetics
Mechanism of drug release from the matrix tablets using different concentration of natural and synthetic polymer can be studied using different mathematical expressions. The kinetic drug-release data were analyzed according to zero order, first order, Higuchi square root, Kosmeyer-Peppas. The appropriate equation was chosen on the basis of goodness of fit test.
3,11
RESULTS
Pre compression parameters
The prepared formulations were evaluated for pre compression parameters and their results were given in table 2 and 3. The powder blend was evaluated for various parameters like angle of repose, tapped density, bulk density, Carr's index and Hausner's ratio respectively. The value of angle of repose of all formulations ranges between 21.22 ± 0.11 to 34.22 ± 0.22 (θ) which shows very good powder flow property. The result of bulk density and tapped density ranges from 0.3861 ± 0.21 to 0.4889 ± 0.22 g/ml and 0.4281 ± 0.05 to 0.4841 ± 0.06 g/ml respectively. The values of compressibility indices, including Carr's index and Hausner's ratio ranged from 12.09 ± 0.04 to 17.82 ± 0.09 and 1.12 ± 0.09 to 1.20 ± 0.09 respectively.
Post compression parameters
The weight of diclofenac loaded matrix tablets was found to be in the range of 0.389 ± 0.004 to 0.399 ± 0.002 gm. Thickness was observed as 1.2 ± 0.1mm and % friability of various formulations was found to be in between 0.06 ± 0.009 to 0.81 ± 0.011. The hardness of tablet was found to be 5.5 ± 0.2 to 7.2 ± 0.2 kg/cm 2 . The in vitro drug release that was performed for HPMC and acacia containing formulations were given in figure 2. The % in vitro drug release from formulations F1, F2, F3, F4, F5 and F6 at the end of 10 h was found to be 79.22 ± 0.032%, 83.22 ± 0.01%, 88.20 ± 0.056%, 77.00 ± 0.013%, 81.02 ± 0.067% and 85.22 ± 0.045% respectively. Drug release kinetics parameters with n, R2 value are provided in (Table 4 ). The regression coefficient value of zero order was observed R2 value 0.949 to 0.994. So, the drug release was found to be zero order kinetics.
DISCUSSION
Pre-compression study of powder blend
The powder blend was evaluated for various parameters as shown in (Table 2 ). This showed that powder blend from all the formulations showing good flow property according to standard values. 
Post-compression studies of prepared matrix tablets
The results of post compression evaluation parameters are given in (Table 3) , and its description given below.
Thickness
The determined thickness according to the die and punches size of all formulation was found to be 1.2 ± 0.001 mm. It was upon the die and punch size during compression of tablets and their total weight.
Weight Variation
The determined weight variation of formulating tablets was found to be in the range of 0.397 ± 0.005 to 0.399 ± 0.002. It was found to be within pharmacopeias limit of ±5% as per I.P.
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Hardness
The hardness of tablet (n=3) of formulation code F1, F2, F3, F4, F5, F6 which was given satisfactory result as per standard. On increasing the concentration of polymer hardness was also increases gradually. Since, high concentration of synthetic polymer enhanced more hardness than natural polymer. 12 The variation of hardness in various formulation codes was shown in (Figure. 1 ).
% Friability
The result of friability was found to be 0.06 ± 0.002 to 0.81 ± 0.032, which was less than 1% as per the pharmacopeias limit. Highest concentrations of polymers in matrix tablet also affect the friability. It showed that tablets have sufficient strength to tolerate transportation stress.
13,14
In vitro Drug Release Study
The in vitro drug release was carried out in phosphate buffer of pH 6.8. The initial drug release was depending upon the water penetration in to the polymeric matrix. The formulations F1 to F6 were given sustained drug release profile for 10 h study as 79.22 ± 0.032%, 83.22 ± 0.012%, 88.20 ± 0.056%, 77.00 ± 0.013%, 81.02 ± 0.067% and 85.22 ± 0.045% respectively. The optimized formulation profile was given by F3 contained 7% concentration of HPMC K4M act as hydrophilic rate retardant property. This indicated that synthetic polymer have more release retardant property than natural polymer. Availability of sufficient time for swelling and gelling was responsible for the slow release of drug. 15 The viscosity of HPMC K4M was more than the acacia so; it was showing better result in matrix tablet. And the hydration rate of HPMC depends on the nature of the substituents like hydroxypropyl group content. Hence, HPMC K4M was formed a strong viscous gel in contact with aqueous media which may be useful in controlled delivery of drug than natural polymer. 5, 7 The comparative in vitro drug release of optimized formulation and marketed formulation was given in (Figure 3 ).
In vitro Drug Release Kinetics
The release kinetics model was used for the goodness of fit by linear regression analysis with the help of zero order, first order, Higuchi's and korsmeyer peppas equation in order to determine release and mechanism of drug action. The regression coefficient value of zero order was observed R 2 value 0.949 to 0.994. So, the drug release was found to be zero order kinetics. The first order equation depends upon the Noyes Whitney equation. Higuchi describes release of drug from insoluble matrix as the square root t dependent release and R 2 value was found to be 0.934 to 0.9897. Korsmeyer peppas describe the mechanism of drug release was found to be non-fickian super case II. 15 The observations of release kinetics of all fabricated and marketed formulations are shown in (Table 4) .
Stability Studies
Stability studies were performed for optimized formulation and marketed formulation at various temperature conditions as room temperature (RT=30 ± 5 0 ), freezing temperature (FT=2-4 ± 2 0 ), and accelerated temperature (AT=45 ± 5 0 ) for 60 days. For F3 slight colour change was seen after 45 days at accelerated condition, but no further defects were seen till 60 days. 16, 17 Marketed preparation was also tested for stability in similar conditions for 60 days. After 45 days slight colour change was observed at room temperature and accelerated conditions. And mottling was also observed after 60 days at accelerated conditions. The stability studies of optimized and marketed preparation were showed in (Table 5, 6 ).
CONCLUSION
From the above study, it was estimated that the synthetic polymer exhibit release over a long period of time than natural polymer. All characterized parameters of drug were found to be within the satisfactory limit. The drug polymer ratio was found to influence the drug release, as the polymer level increased, the drug release rates were found to be decreased. The release of drug after a study of the release kinetics model follows zero order and the mechanism of drug release was found to be non-fickian diffusion super case II. Concentration of natural and synthetic polymer also affects the hardness and drug release profile. Amongst different formulations, F3 (HPMC) was found to be an optimized formulation which gives better results than the marketed formulation on the basis of in vitro release. Thus, it can be concluded that the formulation F3 can be more efficient and potential in comparison with marketed formulation for the development of sustained drug delivery system.
